Genomic features of in vitro selected mutants of Escherichia coli with decreased susceptibility to tigecycline

•Tigecycline (TGC) is a last resort agent for treatment of serious infections caused by XDR bacteria.•In vitro developed TGC resistant isolates of Escherichia coli were studied by whole-genome sequencing.•Alterations in MarR, Lon, AcrB, WaaQ, EptB, RpsI, and RpoB proteins were identified.•Alteration...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of Global Antimicrobial Resistance Ročník 31; s. 32 - 37
Hlavní autoři:	Haeili, Mehri, Shoghi, Yalda, Moghimi, Mohaddeseh, Ghodousi, Arash, Omrani, Maryam, Cirillo, Daniela Maria
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier Ltd 01.12.2022 Elsevier
Témata:	Efflux pumps Escherichia coli Escherichia coli - genetics Fitness cost Genomics Infectious Disease Lipopolysaccharides LPS inner core biosynthesis pathway Microbial Sensitivity Tests Ribosomal protein Tigecycline - pharmacology Tigecycline resistance Tigecycline resistance Efflux pumps Fitness cost LPS inner core biosynthesis pathway Ribosomal protein Escherichia coli ribosomal protein fitness cost efflux pumps
ISSN:	2213-7165, 2213-7173, 2213-7165, 2213-7173
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!